Access Vascular said today that it raised $6 million from new and existing investors for the HyrdoPICC device it developed, earmarking the proceeds for the launch of. HydroPICC, a peripherally inserted central catheter, is made of a proprietary material that’s designed to inhibit the formation of blood clots. It won 510(k) clearance from the FDA […]
Access Vascular logs GPO win with Premier contract
Access Vascular said today that it won a group purchasing agreement for a breakthrough technology with Premier for the HydroPICC peripherally inserted central catheter. Bedford, Mass.-based Access Vascular’s HydroPICC is indicated for reduced thrombus accumulation. The catheter body is composed of biocompatible biomaterial, instead of the standard polyurethane as the material for the body. The […]
Access Vascular raises $3m for anti-clot PICC technology
Access Vascular raised more than $3 million from a consortium of new and existing investors that CEO Jim Biggins said should be sufficient to carry the company through a post-market clinical evaluation of its HydroPICC catheter and into the regulatory process for its next iteration. Biggins told MassDevice.com yesterday that the $3.4 million round was led by […]
Access Vascular raises $2m
Access Vascular has raised $1.9 million in a new round of equity financing, according to an SEC filing posted this week. Money in the round came from seven unnamed sources, with the first sale recorded on May 4, according to the filing. The company is looking for an additional $2.1 million before it plans to close […]
FDA clears Access Vascular’s HydroPICC catheter
Access Vascular said today that its HydroPICC catheter has won 510(k) clearance from the FDA. The peripherally-inserted central catheter is designed with Access Vascular’s proprietary bulk-hydrophilic material, which the company touted as “the ideal material for long-term implantable vascular access devices.” “The FDA clearance of the HydroPICC catheter is an important milestone for Access Vascular […]
Access Vascular raises $4m to support HydroPICC catheter
Medical device developer Access Vascular said today it raised $3.7 million to support its HydroPICC catheter designed to reduce thrombotic risk. The HydroPICC is a peripherally inserted central catheter which the Bedford, Mass.-based company claims can significantly reduce the accumulation of platelets and the risk of thrombosis. Financing will support the submission of an FDA 510(k) […]
